|
Platelets
Citations 261-270 of 382 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Cardiopulmonary Bypass Induces Release of Soluble CD40 Ligand
- Lisa Nannizzi-Alaimo, Mark H. Rubenstein, Veronica L. Alves, Gil Y. Leong, David R. Phillips, and Herman K. Gold
Circulation published May 28, 2002, doi:10.1161/01.CIR.0000019068.32280.B3
[Abstract]
- Correspondence
Activating Effects of GPIIb/IIIa Blockers: An Intrinsic Consequence of Ligand- Mimetic Properties • Response
- K. Peter, M. Schwarz, C. Bode, Andrew L. Frelinger, III, Mark I. Furman, Lori A. Krueger, Marc R. Barnard, and Alan D. Michelson
Circulation 2002;105:e180-181e, doi:10.1161/01.CIR.0000017280.72394.1F
[Full text]
- Clinical Investigations and Reports
Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial
- James L. Januzzi, Jr, Steven M. Snapinn, Peter M. DiBattiste, Ik-Kyung Jang, and Pierre Theroux
Circulation 2002;105:2361-2366; published online before print as doi:10.1161/01.CIR.0000016359.94919.16
[Abstract]
[Full text]
- Articles
Prevention of Inflammation-Induced
Endothelial Dysfunction. A Novel Vasculo-Protective Action of
Aspirin
- Rajesh K. Kharbanda, Benjamin Walton, Meredith Allen, Nigel Klein, Aroon D. Hingorani, Raymond J. MacAllister, and Patrick Vallance
Circulation published May 13, 2002, doi:10.1161/01.CIR.0000017863.52347.6C
[Abstract]
- AHA Conference Proceedings
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
- Robert H. Eckel, Momtaz Wassef, Alan Chait, Burton Sobel, Eugene Barrett, George King, Maria Lopes-Virella, Jane Reusch, Neil Ruderman, George Steiner, and Helen Vlassara
Circulation 2002;105:e138-143e, doi:10.1161/01.CIR.0000013954.65303.C5
[Full text]
- Editorials
Platelet–Monocyte Aggregates: Bridging Thrombosis and Inflammation
- Jane E. Freedman and Joseph Loscalzo
Circulation 2002;105:2130-2132, doi:10.1161/01.CIR.0000017140.26466.F5
[Full text]
- Clinical Investigations and Reports
Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes
- Jaydeep Sarma, Caterina A. Laan, Shirjel Alam, Ashwani Jha, Keith A.A. Fox, and Ian Dransfield
Circulation 2002;105:2166-2171; published online before print as doi:10.1161/01.CIR.0000015700.27754.6F
[Abstract]
[Full text]
- Articles
Benefits and Safety of Tirofiban Among Acute
Coronary Syndrome Patients With Mild to Moderate Renal
Insufficiency. Results From the Platelet Receptor
Inhibition in Ischemic Syndrome Management in Patients Limited
by Unstable Signs and Symptoms (PRISM-PLUS)
Trial.
- James L. Januzzi, Jr, Steven M. Snapinn, Peter M. DiBattiste, Ik-Kyung Jang, and Pierre Theroux
Circulation published April 29, 2002, doi:10.1161/01.CIR.0000016359.94919.16
[Abstract]
- Clinical Investigations and Reports
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
- S. Goya Wannamethee, Gordon D.O. Lowe, Peter H. Whincup, Ann Rumley, Mary Walker, and Lucy Lennon
Circulation 2002;105:1785-1790; published online before print as doi:10.1161/01.CIR.0000016346.14762.71
[Abstract]
[Full text]
- Articles
Increased Platelet Binding to Circulating
Monocytes in Acute Coronary Syndromes
- Jaydeep Sarma, Katja A. Laan, Shirjel Alam, Ashwani Jha, Keith A.A. Fox, and Ian Dransfield
Circulation published April 15, 2002, doi:10.1161/01.CIR.0000015700.27754.6F
[Abstract]
|
|
